| http://www.w3.org/ns/prov#value | - The DOJ entered into a DPA with Pfizer for some of the same conduct relating to its New York subsidiary Pfizer H.C.P. Corporation,497 which, from 1997 to 2006, made improper payments to government officials, including publicly-employed regulators and health care professionals in Bulgaria, Croatia, Kazakhstan and Russia.498 The DOJ did not charge Pfizer in connection with the conduct that was the s
|
